Vicarious Surgical
Vicarious Surgical is a pre-revenue robotics company developing a single-port surgical system for minimally invasive abdominal surgery, featuring miniaturized robotic arms with human-like motion through a 1.5 cm incision, targeting hospitals and ambulatory surgical centers pending FDA clearance.
- Company typePublic
- Founded2014
- HeadquartersWaltham, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Vicarious Surgical does
Vicarious Surgical Inc. is a Waltham, Massachusetts-based robotics company founded in 2014 that is developing a single-port surgical robotics platform for minimally invasive abdominal surgery. The system comprises two main hardware components—a Patient Cart that connects with the patient and a Surgeon Console where the surgeon controls robotic instruments via hand controllers—and is differentiated by a 1.5 cm incision (vs. multi-port conventional robotic surgery), two robotic arms with 13 degrees of freedom each, 28 sensors per arm designed to replicate human upper-body motion from shoulders to wrists, and immersive 3D stereoscopic visualization in which all robotic motion occurs inside the patient to eliminate external collisions. The company received FDA Breakthrough Device Designation and is targeting design freeze by end of 2026 ahead of regulatory submission.
Vicarious Surgical is pre-revenue and has not yet obtained FDA clearance for commercial sale. Its intended revenue model combines capital equipment sales of the surgical system to hospitals and ambulatory surgical centers with recurring revenue from proprietary disposable instruments (including a dedicated suite for ventral hernia repair covering IPOM and rTAPP approaches) and service contracts. Go-to-market is consultative enterprise field sales targeting large hospital systems and academic medical centers, with a clinical collaboration signed in May 2025 with UMass Memorial Medical Center (an 826-bed academic medical center) serving as flagship validation site for workflow, surgeon education, and downstream adoption.
The company went public in September 2021 via a SPAC business combination with D8 Holdings Corp. (NYSE: RBOT), raising approximately $220M, followed by a ~$45M underwritten public offering in August 2023 and a ~$5.9M registered direct offering in October 2025. Under new CEO Stephen From (appointed August 2025), the company has executed a significant operational reset: 2026 cash burn guidance was reduced to approximately $19M from approximately $50M in mid-2025, Q1 2026 operating expenses fell 52% year-over-year to $7.5M, and a strategic software execution partnership with a global digital engineering firm was signed in December 2025 to accelerate development. However, the company received an NYSE delisting notice in March 2026 after market capitalization fell below the $15M minimum, with shares now trading on OTCQB pending a Nasdaq relisting application and reverse stock split. Cash position as of March 31, 2026 was $1.4M in cash and $2.3M in short-term investments, with management stating runway only through Q2 2026 pending additional capital raises.
Vicarious Surgical firmographics
Firmographics- Name
- Vicarious Surgical
- Legal name
- Vicarious Surgical Inc.
- Website
- https://vicarioussurgical.com
- Company type
- Public
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Vicarious Surgical is a pre-revenue robotics company developing a single-port surgical system for minimally invasive abdominal surgery, featuring miniaturized robotic arms with human-like motion through a 1.5 cm incision, targeting hospitals and ambulatory surgical centers pending FDA clearance.
- Ownership category
- akta.pro rank
Vicarious Surgical industry classification
Industry- Product category
- Surgical Robotics
- NAICS
- Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
- akta.pro secondary industries
- Healthcare & Assistive Robotics (HDAAAIAC), Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG), Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH), Operating Room Integration & Surgical Informatics (OR control, documentation, connectivity) (HLAHADAE)
Keywords
Where Vicarious Surgical is headquartered
LocationHeadquarters
- HQ city
- Waltham
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Vicarious Surgical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Others
Revenue model
- Surgical Robotics System Sales: Pre-revenue company developing a single-port surgical robot for minimally invasive abdominal surgery. The company has not yet commercialized its product and has not received FDA clearance. Revenue model will likely involve capital equipment sales to hospitals and ambulatory surgical centers, potentially with recurring revenue from proprietary instruments and service contracts.
- Proprietary Instruments and Consumables: The system uses disposable surgical instruments that would generate recurring revenue per procedure. The company is developing its integrated instrument suite including monopolar scissors for ventral hernia repair procedures.
- Service and Support Contracts: Expected to include installation, training, maintenance, and technical support services associated with capital equipment placement in hospitals and surgical centers.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels8 records
Vicarious Surgical product offering
Product offeringCore offering
Vicarious Surgical develops a single-port robotic surgical system designed for minimally invasive abdominal surgery. The system features two robotic arms with 28 sensors each and 13 degrees of freedom, entering the patient through a 1.5 cm incision and controlled from a surgeon console with immersive 3D visualization and hand controllers. The product has not yet received FDA clearance and is not yet commercialized; the company is targeting ventral hernia repair as its initial procedure focus.
Product overview
Vicarious Surgical offers a single-port surgical robotics platform consisting of the Vicarious Surgical System as the core product. The system comprises two main components: the Patient Cart (patient-side interface enabling robotic entry through a single incision) and the Surgeon Console (where surgeons control instruments and camera using hand controllers and proprietary software). The company is developing a dedicated Surgical Instrument Suite for ventral hernia repair, including monopolar scissors and other core instruments. All robotic motion occurs inside the patient through a 1.5 cm incision, with the system designed to replicate a surgeon's natural upper body movements from shoulders to elbows to wrists.
Differentiator
Problem solved
Functional benefit
Products and services
- Vicarious Surgical System A single-port robotic surgery platform designed for minimally invasive abdominal surgery, comprising a Patient Cart (patient-side interface) and a Surgeon Console with proprietary software and hand controllers. Targets acute care hospitals and ambulatory surgical centers performing abdominal procedures.
- Surgical Instrument Suite for Ventral Hernia Repair Integrated surgical instrument suite including monopolar scissors for energy delivery and cauterization, designed specifically for ventral hernia repair procedures (IPOM and rTAPP approaches) using the Vicarious Surgical System.
Quantifiable outcome
- Incision size as small as 1.2 cm (1.5 cm target with new disposables)
- +3 more outcomes
Companies that use Vicarious Surgical
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles1 record
Vicarious Surgical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Vicarious Surgical partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Global Digital Engineering and Software Development Services Firm (unnamed)coreStrategic software execution partnership to support development of the Vicarious Surgical robotic system. The external partner assumes responsibility for significant software development activities including control systems, visualization, and key workflow components. The partnership aims to increase development velocity, enhance milestone predictability, and reduce operating expenses as part of the company's operational transformation. Partner's global footprint and mature engineering processes are expected to support progress toward design freeze.
- UMass Memorial Medical CentercoreStrategic collaboration signed in May 2025 to support adoption and utilization of Vicarious Surgical's robotic system. Focus areas include streamlining inventory management and sterilization protocols, standardization of pre-procedure processes and post-procedure care, case observation for surgeons, and system testing. The collaboration leverages UMass Memorial's expertise as a leading academic medical center with 826 beds to refine and validate best practices in perioperative workflows.
Scale indicators9 records
Recent moves7 records
Expansion highlights6 records
Vicarious Surgical competitors and assessment
Company assessmentDirect peers
- Intuitive Surgical: The dominant manufacturer of the da Vinci surgical robotics platform for minimally invasive abdominal and pelvic procedures. Intuitive is Vicarious's primary direct competitor; Vicarious must demonstrate clinical and economic advantages sufficient to justify a second platform in da Vinci-equipped hospitals.
- CMR Surgical: UK-based developer of the Versius surgical robotics system, a modular multi-port soft-tissue robot targeting laparoscopic abdominal procedures. Versius is the most analogous emerging single-specialty robotics competitor to Vicarious in Europe and select global markets.
- Asensus Surgical: Developer of the Senhance digital laparoscopy platform, positioned as a lower-cost alternative in soft-tissue minimally invasive surgery. Asensus is a small public peer with a similar capital-constrained commercialization trajectory and a directly overlapping abdominal surgery use case.
Broad incumbents
- Medtronic (Hugo Robotic-Assisted Surgery): Medtronic's Hugo RAS system is a multi-port soft-tissue surgical robotics platform competing directly in the same abdominal minimally invasive surgery market. As a diversified medtech incumbent, Medtronic brings scale, capital, and a global hospital salesforce that Vicarious must contend with in commercialization.
- Johnson & Johnson (Ottava): J&J's Ottava general surgery robotics platform targets the same minimally invasive abdominal market as Vicarious, leveraging J&J's surgical instruments, Ethicon franchise, and global hospital relationships. J&J is also a relevant potential strategic acquirer given its existing investment ecosystem around Vicarious.
Emerging players
- Moon Surgical: French-American early-stage company developing a soft-tissue surgical robotics assistant for laparoscopic abdominal procedures. Moon Surgical represents a comparable single-port-adjacent emerging player competing for similar hospital and ASC customers.
- Activ Surgical: Boston-area developer of AI-driven intraoperative visualization and software for existing laparoscopic and robotic platforms. Activ is an emerging player addressing adjacent surgical decision-support and imaging challenges that complement, but do not directly replicate, Vicarious's robotic platform play.
Others
- Stryker (Mako): While Stryker's Mako platform focuses on orthopedic procedures (knee, hip, spine) rather than soft-tissue abdominal surgery, Stryker is a relevant broader competitor in hospital surgical robotics and a potential strategic acquirer for Vicarious given its pattern of tuck-in medtech M&A.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Vicarious Surgical social profiles
Digital presenceVicarious Surgical compliance and trust
Trust signalCompliance1 record
Vicarious Surgical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vicarious Surgical leadership team
Management profileNumber of profiles
Profiles9 records
Vicarious Surgical funding detail
Funding detailFunding overview
Funding rounds8 records
Investors13 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vicarious Surgical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vicarious Surgical
What does Vicarious Surgical do?
Vicarious Surgical develops a single-port robotic surgical system designed for minimally invasive abdominal surgery. The system features two robotic arms with 28 sensors each and 13 degrees of freedom, entering the patient through a 1.5 cm incision and controlled from a surgeon console with immersive 3D visualization and hand controllers. The product has not yet received FDA clearance and is not yet commercialized; the company is targeting ventral hernia repair as its initial procedure focus.
Is Vicarious Surgical a public or private company?
Vicarious Surgical is a public company. It is classified as public and is currently operating.
When was Vicarious Surgical founded?
Vicarious Surgical was founded in 2014. It employs 101 to 250 people.
Where is Vicarious Surgical based?
Vicarious Surgical is headquartered in Waltham, United States, in the North America region.
How does Vicarious Surgical make money?
Three revenue lines are on record. Surgical Robotics System Sales are the primary driver. The others are proprietary Instruments and Consumables and service and Support Contracts.
Who are Vicarious Surgical's main competitors?
Direct peers on record are Intuitive Surgical, CMR Surgical and Asensus Surgical. Broad incumbents are Medtronic (Hugo Robotic-Assisted Surgery) and Johnson & Johnson (Ottava). Emerging players are Moon Surgical and Activ Surgical. Stryker (Mako) is listed as an others.
Does Vicarious Surgical have an API?
No public API is recorded for Vicarious Surgical.
What industry is Vicarious Surgical in?
Vicarious Surgical's product category is Surgical Robotics. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HDAAAIAC, Healthcare & Assistive Robotics. Its NAICS code is 339112 and its SIC code is 3841.